Custom Recombinant Protein Production Services Market Report 2026

Custom Recombinant Protein Production Services Market Overview

• Custom Recombinant Protein Production Services market size has reached to $5.79 billion in 2025 • Expected to grow to $10.21 billion in 2030 at a compound annual growth rate (CAGR) of 12.1% • Growth Driver: Surge In Targeted And Personalized Therapies Fueling The Growth Of The Market Due To Advances In Precision Medicine • Market Trend: Innovative Expression Systems Enhancing Biopharmaceutical Productivity • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Custom Recombinant Protein Production Services Market?

Custom recombinant protein production services refer to specialized Biotechnology Services that involve the design, expression, and purification of Recombinant Proteins according to specific client requirements. These services integrate molecular cloning, expression systems, purification techniques, and quality control processes to produce proteins for research, therapeutics, and industrial applications. Custom recombinant protein production services help accelerate scientific research, enable development of biologics, and support precise experimental or clinical needs. The main product types of custom recombinant protein production services include antibodies, enzymes, cytokines, growth factors, and recombinant hormones. Antibodies refer to proteins generated to specifically bind target antigens for research, therapeutic, or diagnostic purposes. These services use various expression systems, including mammalian, bacteria, insect, yeast, and other expression systems. They are applied across drug discovery, biopharmaceutical production, diagnostics development, academic research, and industrial enzymes, and are utilized by end users including research institutes, biotechnology and pharmaceutical companies, contract research organizations, and other end-users.

What Is The Custom Recombinant Protein Production Services Market Growth Forecast?

The custom recombinant protein production services market size is expected to see rapid growth in the next few years. It will grow to $10.21 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing development of biologics and biosimilars, rising investments in precision medicine, expansion of contract research outsourcing, growing demand for scalable protein production, increasing adoption of advanced purification technologies. Major trends in the forecast period include increasing demand for custom protein expression services, rising use of mammalian expression systems, growing focus on high-purity protein production, expansion of rapid turnaround research services, enhanced emphasis on quality control and validation.

Global Custom Recombinant Protein Production Services Market Segmentation

1) By Product: Antibodies; Enzymes; Cytokines; Growth Factors; Recombinant Hormones 2) By Expression System: Mammalian; Bacteria; Insect; Yeast; Other Expression Systems 3) By Application: Drug Discovery; Biopharmaceutical Production; Diagnostics Development; Academic Research; Industrial Enzymes 4) By End User: Research Institutes; Biotechnology And Pharmaceutical Companies; Contract Research Organizations (CROs); Other End-Users Subsegments: 1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Chimeric Antibodies; Humanized Antibodies; Single Chain Antibodies 2) By Enzymes: Proteases; Lipases; Amylases; Cellulases; Polymerases 3) By Cytokines: Interleukins; Interferons; Tumor Necrosis Factors; Colony Stimulating Factors; Chemokines 4) By Growth Factors: Epidermal Growth Factors; Fibroblast Growth Factors; Vascular Endothelial Growth Factors; Transforming Growth Factors; Platelet Derived Growth Factors 5) By Recombinant Hormones: Insulin; Erythropoietin; Growth Hormone; Thyroid Stimulating Hormone; Follicle Stimulating Hormone

What Is The Driver Of The Custom Recombinant Protein Production Services Market?

The rising focus on targeted and personalized therapies is expected to propel the growth of the custom recombinant protein production services market going forward. Targeted and personalized therapies refer to medical treatments designed to address individual patient characteristics, such as genetic profile or specific disease markers, to improve treatment effectiveness and reduce side effects. The rise in targeted and personalized therapies is due to advances in precision medicine, which is enabling treatments to be tailored to individual patient biology, improving clinical outcomes and therapeutic efficiency. The custom recombinant protein production services support targeted and personalized therapies by providing precisely engineered proteins required for patient-specific drug development, biomarker targeting, and advanced biologic treatments. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, rising focus on targeted and personalized therapies is driving the growth of the custom recombinant protein production services industry.

Key Players In The Global Custom Recombinant Protein Production Services Market

Major companies operating in the custom recombinant protein production services market are Thermo Fisher Scientific Inc., Merck KGaA, Applied Biological Materials Inc., R&D Systems Inc., GenScript Biotech Corporation, Sino Biological Inc, Biointron Biological Inc., OriGene Technologies Inc., Crown Bioscience Inc., Premas Biotech, Eurofins Discovery, ATUM, BPS Bioscience Inc., Novoprotein Scientific Inc., Kempbio Inc., Proteos Inc., Trenzyme GmbH, LakePharma Inc., Icosagen AS, and ProteoGenix SAS.

Global Custom Recombinant Protein Production Services Market Trends and Insights

Major companies operating in the custom recombinant protein production services market are focusing on introducing innovative microbial expression platforms, such as the proprietary E. coli expression system, to boost protein production, improve scalability, and reduce costs, accelerating the delivery of next-generation biologics. A proprietary E. coli expression system is a specialized, engineered E. coli bacterial strain used to produce recombinant proteins and plasmid DNA with high yield, stability, and efficiency, often tailored for specific biotechnological or pharmaceutical applications. For instance, in March 2025, WuXi Biologics (Cayman) Inc., a China-based contract research, development, and manufacturing organization (CRDMO), launched its new EffiX Microbial Expression Platform. The platform offers impressive titers of over 15 g/L for non-mAb recombinant proteins and more than 1 g/L for plasmid DNA. EffiX is positioned as a comprehensive solution for developing and manufacturing microbial-derived biologics, enhancing scalability, quality, and productivity across the biopharmaceutical industry.

What Are Latest Mergers And Acquisitions In The Custom Recombinant Protein Production Services Market?

In January 2025, NanoImaging Services Inc., a US-based structural biology and imaging company, acquired Proteos Inc. for an undisclosed amount. Through this acquisition, NanoImaging Services aims to integrate Proteos’ expertise in custom recombinant protein production with its advanced imaging and analytical capabilities, offering an end-to-end solution for structure-based drug discovery and protein research. Proteos Inc. is a US-based company specialized in custom recombinant protein production services for research and drug discovery applications.

Regional Insights

North America was the largest region in the custom recombinant protein production services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Custom Recombinant Protein Production Services Market?

The custom recombinant protein production services market consists of revenues earned by entities by providing services such as gene synthesis, vector construction, protein expression in bacterial, yeast, insect, or mammalian systems, purification, characterization, and assay development. Values in this market are ‘factory gate’ values, that is, the value of services or goods provided by the service providers or creators of the proteins, whether to other entities (including downstream research organizations, biotechnology companies, distributors, and academic institutions) or directly to end customers. The value of services in this market includes related offerings sold by the creators of the proteins or platforms.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Custom Recombinant Protein Production Services Market Report 2026?

The custom recombinant protein production services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the custom recombinant protein production services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.